These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29226728)

  • 21. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
    Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Riluzole in Huntington's disease: a 3-year, randomized controlled study.
    Landwehrmeyer GB; Dubois B; de Yébenes JG; Kremer B; Gaus W; Kraus PH; Przuntek H; Dib M; Doble A; Fischer W; Ludolph AC;
    Ann Neurol; 2007 Sep; 62(3):262-72. PubMed ID: 17702031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis.
    Dyer AM; Smith A
    Drug Des Devel Ther; 2017; 11():59-64. PubMed ID: 28053507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study.
    Inoue-Shibui A; Kato M; Suzuki N; Kobayashi J; Takai Y; Izumi R; Kawauchi Y; Kuroda H; Warita H; Aoki M
    BMC Neurol; 2019 Apr; 19(1):72. PubMed ID: 31029113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary toxicity by riluzole.
    González-Fernández C; Güell R; Anton A
    Med Clin (Barc); 2017 Dec; 149(12):561-562. PubMed ID: 28864086
    [No Abstract]   [Full Text] [Related]  

  • 26. Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Arguments against.
    Ludolph AC; Riepe MW
    Neurology; 1999; 53(8 Suppl 5):S46-9; discussion S55-7. PubMed ID: 10560638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosis.
    Bensimon G; Doble A
    Expert Opin Drug Saf; 2004 Nov; 3(6):525-34. PubMed ID: 15500412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Riluzole as a neuroprotective drug for spinal cord injury: from bench to bedside.
    Nagoshi N; Nakashima H; Fehlings MG
    Molecules; 2015 Apr; 20(5):7775-89. PubMed ID: 25939067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term safety of riluzole in amyotrophic lateral sclerosis.
    Lacomblez L; Bensimon G; Leigh PN; Debove C; Bejuit R; Truffinet P; Meininger V;
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):23-9. PubMed ID: 12061945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis.
    Andrews JA; Jackson CE; Heiman-Patterson TD; Bettica P; Brooks BR; Pioro EP
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Nov; 21(7-8):509-518. PubMed ID: 32573277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
    Mitsumoto H; Brooks BR; Silani V
    Lancet Neurol; 2014 Nov; 13(11):1127-1138. PubMed ID: 25316019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limitations of inferences from observational databases in amyotrophic lateral sclerosis: all that glitters is not gold.
    Armon C; Guiloff RJ; Bedlack R
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Sep; 3(3):109-12. PubMed ID: 12495570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyotrophic lateral sclerosis and riluzole use during pregnancy: a case report.
    Scalco RS; Vieira MC; da Cunha Filho EV; Lago EG; da Silva IG; Becker J
    Amyotroph Lateral Scler; 2012 Sep; 13(5):471-2. PubMed ID: 22670879
    [No Abstract]   [Full Text] [Related]  

  • 34. Riluzole: what it does to spinal and brainstem neurons and how it does it.
    Cifra A; Mazzone GL; Nistri A
    Neuroscientist; 2013 Apr; 19(2):137-44. PubMed ID: 22596264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological treatment of ALS.
    Münch C; Ludolph AC
    Neurol Neurochir Pol; 2001; 35(1 Suppl):41-50. PubMed ID: 11732279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Any placebo controlled trial of riluzole would surely be unethical now.
    Ford M; Leperlier C
    BMJ; 2001 Sep; 323(7312):573-4. PubMed ID: 11573491
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
    Noto Y; Shibuya K; Vucic S; Kiernan MC
    Expert Rev Neurother; 2016 Oct; 16(10):1147-54. PubMed ID: 27314534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Riluzole as a treatment for amyotrophic lateral sclerosis].
    Borrás-Blasco J; Plaza-Macías I; Navarro-Ruiz A; Perís-Martí J; Antón-Cano A
    Rev Neurol; 1998 Dec; 27(160):1021-7. PubMed ID: 9951030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Riluzole: a new agent for amyotrophic lateral sclerosis.
    Wagner ML; Landis BE
    Ann Pharmacother; 1997 Jun; 31(6):738-44. PubMed ID: 9184716
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.